Study: 3 out of 4 U.S. Nurses Recommend Health Websites to Patients

Manhattan ResearchApproximately three out of four U.S. nurses recommend health websites to patients, according to the inaugural Taking the Pulse® Nurses v9.0 study from healthcare and pharmaceutical market research company Manhattan Research. The market research and advisory service focuses on which technologies nurses have adopted, how they are currently using them, and how they plan to use them in the future.

The study found that nurses are very savvy when it comes to using technology for health. The average nurse spends eight hours per week online for professional purposes, which is just as much time as physicians, and almost all of them use the Internet in between patient consultations. Nurses are also proactive in researching medical product information specifically online - over eighty percent have visited a pharma, biotech, or device company website in the past year. Merck, AstraZeneca, Pfizer, Eli Lilly, and Sanofi-Aventis have the most-visited corporate sites by nurses.

"While marketers have known for some time that nurses shape patients’ health decisions, they haven't found effective ways to leverage this relationship. This study unequivocally shows that the Internet offers many strong opportunities for marketers to connect with and influence nurses," said Monique Levy, Senior Director of Research at Manhattan Research. "This is great news for marketers, who are struggling to reach and maintain physician mindshare. They have another way into the office."

Sign up for the Taking the Pulse® Nurses v9.0 Webinar - Wednesday, August 26, 11am EDT

Manhattan Research President Mark Bard will host a complimentary webinar previewing the data from the newly released Taking the Pulse® Nurses study, including the latest trends in how nurses use the Internet, mobile devices, social networking, and other technologies as well as how they interact with pharmaceutical companies online.

Taking the Pulse® Nurses v9.0: Nurses and Emerging Information Technologies

Wednesday, August 26, 11:00 - 11:30am EDT

Register here: https://www2.gotomeeting.com/register/369891995

About Taking the Pulse® Nurses
Taking the Pulse® Nurses was conducted in Q2 2009 among a nationally representative sample of 1,001 U.S. practicing nurses and physician assistants (PAs) via online survey methodology.

Taking the Pulse® U.S. Nurses covers topics such as:

  • Internet access, frequency, types, and activities online
  • Overall media consumption (traditional vs. new media)
  • Interest in Web 2.0 technologies for health and pharmaceutical information
  • Professional resource mix, including journals, references, conferences and continuing education
  • Mobile technology adoption, including PDAs/smartphones, drug reference databases, and preferred point of access
  • Advanced online activities such as blogs, podcasting, professional online communities, and wikis
  • Practice technology profile and professional resources, including electronic prescribing and EMR
  • Patient interaction, including emailing/messaging, sites recommended, and influence on treatment decisions

Healthcare and pharmaceutical marketers and other industry stakeholders use Taking the Pulse® Nurses to examine technology, media, channel, and promotional mix strategies as well as to benchmark their performance against industry competitors. In additional to analyzing overall market trends, clients will be able to segment the study to derive statistically relevant insights across 15 nursing specialties, including oncology, diabetes, and cardiology.

For additional product and subscription information, please visit http://www.manhattanresearch.com/ttpnurses

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm. We conduct annual research studies covering eHealth trends among physicians and consumers in the United States, Europe and Asia. For information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...